Olinger G N, Po J, Maloney J V, Mulder D G, Buckberg G D
Ann Surg. 1975 Sep;182(3):292-301. doi: 10.1097/00000658-197509000-00012.
Postoperative mortality, infarction, and need for inotropic support are reportedly increased following myocardial revascularization in "high-risk" patients. We believe these complications result from inadequate protection of the compromised myocardium and should not occur with greater frequency in "high-risk" than "Low-risk" patients if the heart is optimally protected during the entire course of the operative procedure. Results following revascularization in 50 consecutive "low-risk" and 50 consecutive "high-risk" patients were analyzed. One or more of the followin factors were present in the "high-risk" group: ventricular dysfunction--ejection fraction less than 0.4, preinfarction angina, evolving infarction, recent infarction (less than 2 weeks), and refractory ventricular tachyarrhythmia. The following principles were used in all patients to minimize ischemic injury: 1) avoidance of pre-bypass hypo- or hypertension, 2) limitation of ischemic arrest to less than 12 minutes, 3) avoidance of ventricular fibrillation, and 4) prolongation of total bypass as necessary to repay the myocardial oxygen debt. Postoperative inotropic support was required in 10% of "high" and 10% of "low-risk" patients, new postoperative infarction developed in 10% of "high" vs. 10% "low-risk" patients; death occurred in 2% of "high" vs. 4% "low-risk" patients. These results are comparable and indicate that optimum myocardial protection allows safe revascularization in the "high-risk" patient.
据报道,“高危”患者心肌血运重建术后的死亡率、梗死发生率及对正性肌力支持的需求均有所增加。我们认为,这些并发症是由于对受损心肌保护不足所致,如果在整个手术过程中心脏得到最佳保护,那么“高危”患者出现这些并发症的频率不应高于“低危”患者。分析了连续50例“低危”患者和连续50例“高危”患者血运重建后的结果。“高危”组存在以下一种或多种因素:心室功能障碍——射血分数小于0.4、梗死前心绞痛、进展性梗死、近期梗死(小于2周)及难治性室性快速心律失常。所有患者均采用以下原则以尽量减少缺血性损伤:1)避免体外循环前低血压或高血压;2)将缺血停搏时间限制在12分钟以内;3)避免心室颤动;4)必要时延长总体外循环时间以偿还心肌氧债。“高危”患者中有10%、“低危”患者中有10%术后需要正性肌力支持;“高危”患者中有10%、“低危”患者中有10%发生了新的术后梗死;“高危”患者中有2%死亡,“低危”患者中有4%死亡。这些结果具有可比性,表明最佳心肌保护可使“高危”患者安全地进行血运重建。